A study of Swedish registry data has found that women who received the HPV vaccine before their first pregnancy had 15% lower odds of very preterm birth, according to reporting by Medical Daily. News-Medical reports that the research points to possible pregnancy-related benefits from a vaccine already known to protect against cancer.
The findings were covered across several outlets, including U.S. News & World Report, which reported that the HPV vaccine may offer benefits beyond cancer protection. CIDRAP reported that mothers vaccinated against HPV before pregnancy were less likely to give birth prematurely. Contemporary OB/GYN described the result as the vaccine being tied to fewer adverse pregnancy outcomes.
The HPV vaccine is established as a tool against cancers linked to human papillomavirus. The new angle here is reproductive: whether vaccination before a first pregnancy is associated with better birth outcomes. The reported 15% figure comes from Swedish registry data, a type of observational record that can show links between vaccination and outcomes but does not by itself prove that the vaccine causes the difference.
The coverage so far is based on the same underlying study, with each outlet emphasizing a different part of the result. Details such as the study's design, the size of the population examined, and how researchers accounted for other factors were not available in the source material.
What to watch next: whether the full study is published with peer review, and whether other datasets reproduce the association between pre-pregnancy HPV vaccination and very preterm birth.
